STAT3 and Hepatic fibrosis: sIRNAs or ASO targeting STAT3 was packaged into clinical grade fibroblast-like MSC-derived EVs by electroporation significantly downregulated STAT3 levels as well as improved liver function in liver fibrosis mice [115].